副甲状腺機能低下症治療とは、副甲状腺機能低下症によって副甲状腺ホルモンの分泌量が低下した状態を治療することです。副甲状腺ホルモンは、カルシウムとリンのバランスを維持・調整する働きがあります。胸部手術の増加や癌の発生率、新薬開発、政府の支援などにより、予測期間中に副甲状腺機能低下症治療が採用されるようになりました。たとえば、2020年に国立癌研究所によると、アメリカでは新たに1,806,590人の癌患者が診断され、606,520人がこの病気で死亡すると推定されています。また、技術的に高度な治療法の採用が進み、副甲状腺機能低下症治療の採用＆需要が予測期間中に市場成長を高めると思われます。しかし、臨床承認サイクルの長さが、2021年から2027年の予測期間における市場成長を阻害しています。
世界の副甲状腺機能低下症治療市場分析の対象となる地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域が含まれます。北アメリカは、甲状腺関連疾患の増加や製薬企業による新規製剤の創出への取り組みが活発化していることから、世界的に見ても主要な地域となっています。一方、アジア太平洋地域は、2021年から2027年の予測期間にかけて最も高い成長率を示すと予想されています。ジェネリックメーカーの存在などの要因は、アジア太平洋地域の副甲状腺機能低下症治療市場に有利な成長見通しを生み出すでしょう。
この調査の目的は、近年のさまざまなセグメントおよび国々の市場規模を定義し、今後8年間の価値を予測することです。本レポートは、調査対象となる各地域・国における産業の質的・量的側面を取り込むように設計されています。さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合状況や製品提供の詳細な分析とともに、利害関係者が投資するミクロ市場での機会についても報告します。
目次
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Global Hypoparathyroidism Treatment Market, by Region, 2019-2027 (USD Billion)
1.2.2. Global Hypoparathyroidism Treatment Market, by Product, 2019-2027 (USD Billion)
1.2.3. Global Hypoparathyroidism Treatment Market, by Administration, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Hypoparathyroidism Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Hypoparathyroidism Treatment Market Dynamics
3.1. Hypoparathyroidism Treatment Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing number of thoracic surgeries and incidence of cancer
3.1.1.2. New drug development and government support
3.1.2. Market Challenges
3.1.2.1. Lengthy clinical approval cycles
3.1.3. Market Opportunities
3.1.3.1. Increasing adoption of technologically advanced treatment
Chapter 4. Global Hypoparathyroidism Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Hypoparathyroidism Treatment Market, by Product
6.1. Market Snapshot
6.2. Global Hypoparathyroidism Treatment Market by Product, Performance - Potential Analysis
6.3. Global Hypoparathyroidism Treatment Market Estimates & Forecasts by Product, 2018-2027 (USD Billion)
6.4. Hypoparathyroidism Treatment Market, Sub Segment Analysis
6.4.1. Parathyroid Hormone
6.4.2. Vitamin D Analogue
6.4.3. Calcium Supplements
Chapter 7. Global Hypoparathyroidism Treatment Market, by Administration
7.1. Market Snapshot
7.2. Global Hypoparathyroidism Treatment Market by Administration, Performance - Potential Analysis
7.3. Global Hypoparathyroidism Treatment Market Estimates & Forecasts by Administration, 2018-2027 (USD Billion)
7.4. Hypoparathyroidism Treatment Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Parenteral
Chapter 8. Global Hypoparathyroidism Treatment Market, Regional Analysis
8.1. Hypoparathyroidism Treatment Market, Regional Market Snapshot
8.2. North America Hypoparathyroidism Treatment Market
8.2.1. U.S. Hypoparathyroidism Treatment Market
8.2.1.1. Product breakdown estimates & forecasts, 2018-2027
8.2.1.2. Administration breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Hypoparathyroidism Treatment Market
8.3. Europe Hypoparathyroidism Treatment Market Snapshot
8.3.1. U.K. Hypoparathyroidism Treatment Market
8.3.2. Germany Hypoparathyroidism Treatment Market
8.3.3. France Hypoparathyroidism Treatment Market
8.3.4. Spain Hypoparathyroidism Treatment Market
8.3.5. Italy Hypoparathyroidism Treatment Market
8.3.6. Rest of Europe Hypoparathyroidism Treatment Market
8.4. Asia-Pacific Hypoparathyroidism Treatment Market Snapshot
8.4.1. China Hypoparathyroidism Treatment Market
8.4.2. India Hypoparathyroidism Treatment Market
8.4.3. Japan Hypoparathyroidism Treatment Market
8.4.4. Australia Hypoparathyroidism Treatment Market
8.4.5. South Korea Hypoparathyroidism Treatment Market
8.4.6. Rest of Asia Pacific Hypoparathyroidism Treatment Market
8.5. Latin America Hypoparathyroidism Treatment Market Snapshot
8.5.1. Brazil Hypoparathyroidism Treatment Market
8.5.2. Mexico Hypoparathyroidism Treatment Market
8.6. Rest of The World Hypoparathyroidism Treatment Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Shire NPS Pharmaceuticals Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Takeda Pharmaceutical Company Limited.
9.2.3. Entera Bio Ltd.
9.2.4. Amgen Inc.
9.2.5. Ascendis Pharma A/S
9.2.6. F. Hoffmann-La Roche Ltd
9.2.7. ProLynx, Inc.
9.2.8. Extend Biosciences, Inc.
9.2.9. BionPharma Inc.
9.2.10. F Hoffmann-La Roche Ltd.,
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
List of Tables
TABLE 1. Global Hypoparathyroidism Treatment market, report scope
TABLE 2. Global Hypoparathyroidism Treatment market estimates & forecasts by Region 2018-2027 (USD Billion)
TABLE 3. Global Hypoparathyroidism Treatment market estimates & forecasts by Product 2018-2027 (USD Billion)
TABLE 4. Global Hypoparathyroidism Treatment market estimates & forecasts by Administration 2018-2027 (USD Billion)
TABLE 5. Global Hypoparathyroidism Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 6. Global Hypoparathyroidism Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Hypoparathyroidism Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Hypoparathyroidism Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Hypoparathyroidism Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Hypoparathyroidism Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Hypoparathyroidism Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Hypoparathyroidism Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Hypoparathyroidism Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Hypoparathyroidism Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. U.S. Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 17. U.S. Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. Canada Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Canada Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 20. Canada Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. UK Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. UK Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 23. UK Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. Germany Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 25. Germany Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 26. Germany Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. RoE Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 28. RoE Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 29. RoE Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. China Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 31. China Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 32. China Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. India Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 34. India Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 35. India Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. Japan Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 37. Japan Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 38. Japan Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. RoAPAC Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 40. RoAPAC Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 41. RoAPAC Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. Brazil Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 43. Brazil Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 44. Brazil Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Mexico Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 46. Mexico Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 47. Mexico Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. RoLA Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 49. RoLA Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 50. RoLA Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. Row Hypoparathyroidism Treatment market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 52. Row Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 53. Row Hypoparathyroidism Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Hypoparathyroidism Treatment market
TABLE 55. List of primary sources, used in the study of global Hypoparathyroidism Treatment market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered
List of figures
FIG 1. Global Hypoparathyroidism Treatment market, research methodology
FIG 2. Global Hypoparathyroidism Treatment market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Hypoparathyroidism Treatment market, key trends 2020
FIG 5. Global Hypoparathyroidism Treatment market, growth prospects 2021-2027
FIG 6. Global Hypoparathyroidism Treatment market, porters 5 force model
FIG 7. Global Hypoparathyroidism Treatment market, pest analysis
FIG 8. Global Hypoparathyroidism Treatment market, value chain analysis
FIG 9. Global Hypoparathyroidism Treatment market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Hypoparathyroidism Treatment market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Hypoparathyroidism Treatment market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Hypoparathyroidism Treatment market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Hypoparathyroidism Treatment market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Hypoparathyroidism Treatment market, regional snapshot 2018 & 2027
FIG 15. North America Hypoparathyroidism Treatment market 2018 & 2027 (USD Billion)
FIG 16. Europe Hypoparathyroidism Treatment market 2018 & 2027 (USD Billion)
FIG 17. Asia pacific Hypoparathyroidism Treatment market 2018 & 2027 (USD Billion)
FIG 18. Latin America Hypoparathyroidism Treatment market 2018 & 2027 (USD Billion)
FIG 19. Global Hypoparathyroidism Treatment market, company market share analysis (2020)
